Kohn EC - Search Results

1

Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.

Gunn AJ, Hama Y, Koyama Y, Kohn EC, Choyke PL, Kobayashi H. Gunn AJ, et al. Among authors: kohn ec. Cancer Sci. 2007 Nov;98(11):1727-33. doi: 10.1111/j.1349-7006.2007.00602.x. Epub 2007 Sep 2. Cancer Sci. 2007. PMID: 17784874 Free PMC article.

2

In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.

Kohn EC, Sandeen MA, Liotta LA. Kohn EC, et al. Cancer Res. 1992 Jun 1;52(11):3208-12. Cancer Res. 1992. PMID: 1591730

3

CAI inhibits the growth of small cell lung cancer cells.

Moody TW, Chiles J, Moody E, Sieczkiewicz GJ, Kohn EC. Moody TW, et al. Among authors: kohn ec. Lung Cancer. 2003 Mar;39(3):279-88. doi: 10.1016/s0169-5002(02)00525-1. Lung Cancer. 2003. PMID: 12609566

4

Proteomic analysis for early detection of ovarian cancer: a realistic approach?

Stevens EV, Liotta LA, Kohn EC. Stevens EV, et al. Among authors: kohn ec. Int J Gynecol Cancer. 2003 Nov-Dec;13 Suppl 2:133-9. doi: 10.1111/j.1525-1438.2003.13358.x. Int J Gynecol Cancer. 2003. PMID: 14656269 Review.

5

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.

Davidson B, Alejandro E, Flørenes VA, Goderstad JM, Risberg B, Kristensen GB, Trope CG, Kohn EC. Davidson B, et al. Among authors: kohn ec. Cancer. 2004 May 15;100(10):2139-47. doi: 10.1002/cncr.20219. Cancer. 2004. PMID: 15139056 Free article.

6

Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma.

Stevens EV, Raffeld M, Espina V, Kristensen GB, Trope' CG, Kohn EC, Davidson B. Stevens EV, et al. Among authors: kohn ec. Cancer. 2005 Jun 1;103(11):2313-9. doi: 10.1002/cncr.21031. Cancer. 2005. PMID: 15844177 Free article.

7

Asparagine synthetase as a causal, predictive biomarker for L-asparaginase activity in ovarian cancer cells.

Lorenzi PL, Reinhold WC, Rudelius M, Gunsior M, Shankavaram U, Bussey KJ, Scherf U, Eichler GS, Martin SE, Chin K, Gray JW, Kohn EC, Horak ID, Von Hoff DD, Raffeld M, Goldsmith PK, Caplen NJ, Weinstein JN. Lorenzi PL, et al. Among authors: kohn ec. Mol Cancer Ther. 2006 Nov;5(11):2613-23. doi: 10.1158/1535-7163.MCT-06-0447. Epub 2006 Nov 6. Mol Cancer Ther. 2006. PMID: 17088436

8

A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer.

Posadas EM, Liel MS, Kwitkowski V, Minasian L, Godwin AK, Hussain MM, Espina V, Wood BJ, Steinberg SM, Kohn EC. Posadas EM, et al. Among authors: kohn ec. Cancer. 2007 Apr 1;109(7):1323-30. doi: 10.1002/cncr.22545. Cancer. 2007. PMID: 17330838 Free PMC article. Clinical Trial.

9

A prospective analysis of imatinib-induced c-KIT modulation in ovarian cancer: a phase II clinical study with proteomic profiling.

Posadas EM, Kwitkowski V, Kotz HL, Espina V, Minasian L, Tchabo N, Premkumar A, Hussain MM, Chang R, Steinberg SM, Kohn EC. Posadas EM, et al. Among authors: kohn ec. Cancer. 2007 Jul 15;110(2):309-17. doi: 10.1002/cncr.22757. Cancer. 2007. PMID: 17559139 Free article. Clinical Trial.

10

Ovarian cancer in the proteomics era.

Annunziata CM, Azad N, Dhamoon AS, Whiteley G, Kohn EC. Annunziata CM, et al. Among authors: kohn ec. Int J Gynecol Cancer. 2008 Mar-Apr;18 Suppl 1:1-6. doi: 10.1111/j.1525-1438.2007.01096.x. Int J Gynecol Cancer. 2008. PMID: 18336391 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

291 results

Search Page

Filters